Analytical services center for medications development. Single award R & D IDIQ contract. July 20, 2026 - july 19, 2031.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00031
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $860,891 obligated
Award facts
- Opportunity
-
- Analytical Services Center for Medications Development Program Pre-Solicitation · 75N95024R00032 · Posted Dec 14, 2023
- Combined order value
- $860,891 Current and potential, with all options
- Last date to order 6% complete
- IDV ceiling 17% used
- $5,000,000.00
- Maximum order
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded an indefinite-delivery contract to Mriglobal (doing business as Midwest Research Institute) on July 20, 2026, with a $5 million ceiling through July 19, 2031. This is a multiple-award IDIQ for analytical services supporting the Analytical Services Center for Medications Development.
The originating solicitation sought bioanalytical chemistry resources to support medications development, including quantitative and qualitative assays of compounds in preclinical and clinical samples, method development and validation, and data management and archival services. Vendors required DEA registration for Schedules II through V with ability to apply for Schedule I, and demonstrated GLP analytical experience. NAICS 541712 and PSC D399 apply.
Place of performance is Kansas City, Missouri (64110). The period of performance runs from July 20, 2026 through July 19, 2031, with no stated base and option structure.
Two task orders issued under this IDIQ on the award date: Task Order 01 carries a $382,839 ceiling for Phase 1 single ascending dose pharmacokinetics study analytical services, and Task Order 02 carries a $478,052 ceiling for Phase 1 single ascending dose pharmacokinetics study parent/metabolite analysis, both running through January 19, 2028 with cost-plus-fixed-fee pricing and performance in Kansas City.
Task orders
Quick answers
Who was awarded contract 75N98026D00031?
75N98026D00031 was awarded to Mriglobal by Office of Logisitics and Acquisition Operations (National Institutes of Health) on July 20, 2026.
How much is contract 75N98026D00031 worth?
Orders under 75N98026D00031 have obligated $860,891. 75N98026D00031's own ceiling is $5,000,000. A single order can be worth up to $5,000,000.
How many orders have been placed under contract 75N98026D00031?
2 orders have been placed under 75N98026D00031, the latest on July 20, 2026.
Which agency awarded contract 75N98026D00031?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00031, with funding from National Institute on Drug Abuse (National Institutes of Health).
Who can order from contract 75N98026D00031?
75N98026D00031 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00031 competed?
The extent of competition for 75N98026D00031 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV